UPMC Enterprises on Tuesday announced its first round of funding for six projects under the Pittsburgh Health Data Alliance umbrella, a year-old collaboration of hospital system UPMC, University of Pittsburgh and Carnegie Mellon University.
UPMC’s funding will exceed $3 million over the next six months for technologies that are aimed at reducing patient falls, reducing the incidence of pressure ulcers, improving the accuracy of cancer diagnosis and other projects.
Receiving funding at CMU was the Clinical Genomics Modeling Platform at the university’s Center for Machine Learning and Health. The platform is an engine for building precision medicine models for various diseases.
Five other projects being developed through Pitt’s Center for Commercial Applications of Healthcare Data also received funding:
■ MedIvate, a smartphone application that will make it easy for patients to update and share medication lists;
■ Tumor-specific Driver Identification System, software that will provide personalized genomic information to doctors about the genetic drivers of an individual patient’s tumors;
■ Fall Sentinel, an automated system that will enable pharmacists to monitor potential drug reactions in nursing home patients, which could increase the risk of falling;
■ PUMP, wearable devices and hospital bed sensors that will provide real-time documentation of patient repositioning that is necessary to prevent and treat bed sores;
■ ComPACD, software that will help pathologists improve cancer diagnosis from complex tumor images.
The progress made by each group could open the door to future funding by UPMC Enterprises. The Pittsburgh Health Data Alliance was formed in March 2015.
Kris B. Mamula: email@example.com, or 412-263-1699.